I

IMVT

IMVT

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
IMVT Live QuoteReal-time
$32.52
+$4.14(+14.59%)1M
Day Range$32.33 – $33.95
Open$33.71
Previous Close$33.17
Volume731.1K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$6.73B
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-2.56
Price to Book10.4
Dividend Yield0.65%
Beta (Volatility)0.94
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $32.52 (45%)
Low: $21.93High: $45.42
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$48.62-67.6% upside

Insider Buys

0

$0

Insider Sales

3

$367K

Total Volume

$367K

3 transactions

Net Activity

$367K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
35CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
G
1

Girao Tiago

CFO

0 buys1 sells

$188K total

V
2

Van Tuyl Christopher

GC

0 buys1 sells

$103K total

S
3

Stout Jay S

CTO

0 buys1 sells

$75K total

Trading History
IMVT insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 28, 2026

3 weeks ago

Girao Tiago

CFO

CFO
Sell6.6K$28.50$188K

Oct 21, 2026

1 months ago

Stout Jay S

CTO

CTO
Sell2.6K$28.94$75K

Sep 23, 2026

1 months ago

Van Tuyl Christopher

GC

General Counsel
Sell2.8K$36.36$103K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
IMVT Buy Conviction0%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

IMVT has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for IMVT

Over the last 90 days, corporate insiders at IMVT (IMVT) engaged in a total of 3 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 3 were sales. The total volume of insider trading reached $367K.

The net insider activity for IMVT shows a net selling bias of $367K. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Girao Tiago (CFO), who traded 6.6K shares valued at $188K on Oct 28, 2026.

Live Market News & Developments
Aggregated real-time headlines for IMVT (IMVT)
6 updates

Immunovant (IMVT) Stock Looks Stretched On Book Value Alone

Yahoo Finance31d ago

IMVT - Immunovant Inc Stock Price and Quote

Finviz177d ago

Immunovant: Upgraded To 'Buy' Because Of IMVT-1402's Broad Potential (NASDAQ:IMVT)

Seeking Alpha179d ago

Immunovant Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Immunovant (IMVT)

PR Newswire56d ago

Immunovant (IMVT) Stock Looks Expensive Based On Its Book Value

Yahoo Finance67d ago

These Two Biotech Stocks Rocketed — And One Just Broke Out

Investor's Business Daily184d ago

FAQs About IMVT Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for IMVT.

Based on SEC Form 4 disclosures, the Insider Confidence Score for IMVT is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 3 sales by company executives over the last 90 days.

The CEO Conviction Index for IMVT is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.